Neuromodulation therapy guidelines may help to improve the safe and efficient use of neuromodulation implants in patient-centered therapy.
An evidence-based guidance on the safe and efficient use of neuromodulation implants in patient-centered therapy was published by the International Neuromodulation Society (INS) journla Neuromodulation: Technology at the Neural Interface. The guidance, in six publications by more than 60 international experts, collectively reviews more than 600 publications that appeared in the scientific literature by 2014.
‘Recommendations on specific issues to improve patient suffering was included in the consensus by International Neuromodulation Society (INS).’
The articles provide recommendations about specific issues to improve suffering in patients who live with a variety of chronic conditions.The INS executive officers convened the international experts who systematically rank evidence and present decision trees and flow charts concerning patient care.
"Interest in targeted delivery of chemical agents has grown in part because intrathecal drug delivery requires perhaps just 1% of an oral dose, and is not prone to painkiller diversion or misuse," commented INS President Timothy Deer, M.D. "Meanwhile neurostimulation treats disease symptoms without relying on medication, by applying targeted electrical stimulation."
The Neuromodulation Appropriateness Consensus Committee first issued neurostimulation therapy guidance in four articles in 2014 that have been cited more than 100 times.
Since then, newer spinal cord stimulation systems have entered the clinic that vary the electrical stimulus pattern or frequency, or target a different part of the spinal cord involved in pain perception.
Advertisement
Advertisement